-
2023.07.12Pharma DJ: SanegeneBio: an innovator for RNAi drugsPharmaDJ interviewed SanegeneBio's CEOMore
-
2023.01.05Business Wire: Orbit Discovery and SanegeneBio Collaborate to Identify Targeting Peptides for RNAi DrugsWe are delighted to leverage the speed and performance of the Orbit platform to enable Sanegene to generate specific targeting peptides.More
